ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Latigo Biotherapeutics, Inc. | — | United States of America | — | 31 |
| HJ Science Co., Ltd. | — | Hong Kong | — | 30 |
| Shaanxi Micot Pharmaceutical Technology Co., Ltd. | — | Hong Kong | — | 30 |
| IMBiologics Corp. | 493280 | South Korea | — | 29 |
| BIONET Therapeutics Corp. | 7808 | Taiwan | — | 28 |
| Cardiogeni Plc | — | United Kingdom | — | 28 |
| Vogenx, Inc. | — | United States of America | — | 27 |
| Brainstorm Cell Therapeutics Inc | BCLI | United States of America | — | 26 |
| Syros Pharmaceuticals, Inc. | 0LC7 | United States of America | — | 25 |
| Gracell Biotechnologies Inc. | GRCL | United States of America | — | 23 |
| Intelligene Inc. | 7832 | Taiwan | — | 23 |
| SL Science Holding Ltd | — | Cayman Islands | — | 23 |
| Osta Biotechnologies Inc. | OBI.H | Canada | — | 22 |
| BoYen Therapeutics,Inc. | 7891 | Taiwan | — | 20 |
| Elixiron Immunotherapeutics (Cayman) Limited | 7871 | Taiwan | — | 20 |
| LIBO PHARMA CORP. | 7888 | Taiwan | — | 20 |
| UWELL BIOPHARMA INC. | 7902 | Taiwan | — | 20 |
| Curevac | CVAC | Netherlands | — | 13 |
| TLC BioSciences Corp. | 7924 | Taiwan | — | 11 |
| Tripartite Therapeutics Inc. | 7920 | Taiwan | — | 11 |
| Ingenia Therapeutics (인제니아테라퓨틱스) | 950260 | South Korea | — | 10 |
| Windtree Therapeutics Inc | WINT | United States of America | — | 7 |
| Bioxytran, Inc. | — | United States of America | — | 6 |
| Harvard Apparatus Regenerative Technology, Inc. (formerly Biostage, Inc.) | — | United States of America | — | 6 |
| ZyVersa Therapeutics Inc. | ZVSA | United States of America | — | 5 |
| Cessatech A/S | CESSA | Denmark | — | 4 |
| Vincerx Pharma, Inc. Common Stock | VINC | United States of America | — | 2 |
| Lipella Pharmaceuticals Inc. Common Stock | LIPO | United States of America | — | 1 |
| Seelos Therapeutics, Inc. | SEELQ | United States of America | — | 1 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.